Friday, October 25, 2019

Neurology/Neuroscience Research Seminar - Presented by Dr. Jennifer Magnusson, Research Fellow, Department of Neurology - Friday, October 25th, 2019

12:00 PM to 1:00 PM

Biomedical Science Research Building (BSRB), Room 5515, 109 Zina Pitcher Place, Ann Arbor, MI 48109

“A reversal of fate: unravelling the role of central 5-HT in cardiovascular control in neonatal and adult rodents”


We are interested in the extent to which a specific loss of 5-hydroxytryptamine (5- HT) affects the control of arterial blood pressure (ABP) and heart rate (HR) across vigilance-states based on existing evidence suggesting that 5-HT defects increase the risk for Sudden Infant Death Syndrome (SIDS) and neurogenic hypertension. SIDS is the leading cause of infant mortality between 1 month and 1 year of age, occurs during sleep, and up to 70% of all SIDS cases have at least one 5-HT system abnormality. Neonatal rodents lacking central 5-HT exhibit severe apneas, and a reduced ABP and HR. Central 5-HT has also been implicated in the etiology of neurogenic hypertension, presumably due to projections of 5-HT neurons within the midline raphe to vagal and presympathetic regions of the brain. However, data from studies examining the specific role of central 5-HT function is conflicting or inconclusive. Neurogenic hypertension accounts for more than 90% of all hypertensive cases and the normal fall in ABP that occurs during non-rapid eye movement sleep is absent in some patients with hypertension. Understanding the mechanisms associated with the development of hypertension is critical not only to lower blood pressure, but to lower its associated cardiovascular events. The purpose of this project was to examine the role of central 5-HT in the control of ABP during sleep and reveal, mechanistically, the physiological role of 5-HT in the autonomic control of ABP in neonatal and adult rodents. Our overarching hypothesis was that central 5-HT is required for the maintenance of ABP and autonomic tone at rest in both neonatal and adult rodents.

Accreditation and Credit Designation:

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Michigan Medical School designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Scan the QR code to register your attendance.

*For iOS devices: Open the phone's camera app and hover over the code. When the notification box appears, tap on it to open the credit claiming screen.
For Android Devices: A QR reader is required. Visit the Google Play store to download a QR app of your choice. Follow the scanning directions provided by the app.

* Please Note: Attendance must be registered within 6 months to be awarded credit. To complete an evaluation for this session, please login to MiCME and go to the Claim Credits & Print Transcripts page.

“A reversal of fate: unravelling the role of central 5-HT in cardiovascular control in neonatal and adult rodents”

Dr. Jennifer Magnusson

Jennifer Magnusson, PhD

Research Fellow, Department of Neurology